nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—OPRD1—coronary artery disease	0.371	1	CbGaD
Alvimopan—Quinapril—Perindopril—coronary artery disease	0.0775	0.156	CrCrCtD
Alvimopan—Quinapril—Enalapril—coronary artery disease	0.0605	0.122	CrCrCtD
Alvimopan—Quinapril—Trandolapril—coronary artery disease	0.0605	0.122	CrCrCtD
Alvimopan—Benazepril—Enalapril—coronary artery disease	0.0576	0.116	CrCrCtD
Alvimopan—Benazepril—Trandolapril—coronary artery disease	0.0576	0.116	CrCrCtD
Alvimopan—Quinapril—Lisinopril—coronary artery disease	0.0473	0.0955	CrCrCtD
Alvimopan—Quinapril—Ramipril—coronary artery disease	0.0458	0.0925	CrCrCtD
Alvimopan—Benazepril—Lisinopril—coronary artery disease	0.0451	0.091	CrCrCtD
Alvimopan—Benazepril—Ramipril—coronary artery disease	0.0437	0.0881	CrCrCtD
Alvimopan—Back pain—Pitavastatin—coronary artery disease	0.000876	0.013	CcSEcCtD
Alvimopan—Hypokalaemia—Acetylsalicylic acid—coronary artery disease	0.000828	0.0123	CcSEcCtD
Alvimopan—Connective tissue disorder—Gemfibrozil—coronary artery disease	0.000724	0.0107	CcSEcCtD
Alvimopan—Urinary tract disorder—Ticagrelor—coronary artery disease	0.000711	0.0105	CcSEcCtD
Alvimopan—Connective tissue disorder—Ticagrelor—coronary artery disease	0.000707	0.0105	CcSEcCtD
Alvimopan—Urethral disorder—Ticagrelor—coronary artery disease	0.000706	0.0105	CcSEcCtD
Alvimopan—Hypokalaemia—Eplerenone—coronary artery disease	0.000694	0.0103	CcSEcCtD
Alvimopan—Dyspepsia—Pitavastatin—coronary artery disease	0.000651	0.00964	CcSEcCtD
Alvimopan—Urinary retention—Niacin—coronary artery disease	0.000648	0.0096	CcSEcCtD
Alvimopan—Hypokalaemia—Olmesartan—coronary artery disease	0.000635	0.00941	CcSEcCtD
Alvimopan—Flatulence—Gemfibrozil—coronary artery disease	0.000632	0.00936	CcSEcCtD
Alvimopan—Constipation—Pitavastatin—coronary artery disease	0.000632	0.00936	CcSEcCtD
Alvimopan—Malnutrition—Ticagrelor—coronary artery disease	0.000627	0.00928	CcSEcCtD
Alvimopan—Back pain—Ticagrelor—coronary artery disease	0.000606	0.00898	CcSEcCtD
Alvimopan—Anaemia—Gemfibrozil—coronary artery disease	0.000593	0.00878	CcSEcCtD
Alvimopan—Hypokalaemia—Telmisartan—coronary artery disease	0.000583	0.00863	CcSEcCtD
Alvimopan—Urinary retention—Perindopril—coronary artery disease	0.000575	0.00851	CcSEcCtD
Alvimopan—Urinary retention—Furosemide—coronary artery disease	0.000559	0.00828	CcSEcCtD
Alvimopan—Flatulence—Rosuvastatin—coronary artery disease	0.000556	0.00823	CcSEcCtD
Alvimopan—Connective tissue disorder—Fenofibrate—coronary artery disease	0.000553	0.00819	CcSEcCtD
Alvimopan—Urinary tract disorder—Clopidogrel—coronary artery disease	0.000546	0.00809	CcSEcCtD
Alvimopan—Urethral disorder—Clopidogrel—coronary artery disease	0.000542	0.00803	CcSEcCtD
Alvimopan—Dyspepsia—Penbutolol—coronary artery disease	0.00054	0.008	CcSEcCtD
Alvimopan—Hypokalaemia—Furosemide—coronary artery disease	0.000535	0.00792	CcSEcCtD
Alvimopan—Connective tissue disorder—Ezetimibe—coronary artery disease	0.000529	0.00784	CcSEcCtD
Alvimopan—Urinary tract disorder—Eplerenone—coronary artery disease	0.000521	0.00771	CcSEcCtD
Alvimopan—Connective tissue disorder—Eplerenone—coronary artery disease	0.000518	0.00767	CcSEcCtD
Alvimopan—Urethral disorder—Eplerenone—coronary artery disease	0.000517	0.00765	CcSEcCtD
Alvimopan—Anaemia—Acetylsalicylic acid—coronary artery disease	0.000507	0.0075	CcSEcCtD
Alvimopan—Malnutrition—Fenofibrate—coronary artery disease	0.00049	0.00725	CcSEcCtD
Alvimopan—Flatulence—Fenofibrate—coronary artery disease	0.000482	0.00714	CcSEcCtD
Alvimopan—Malnutrition—Clopidogrel—coronary artery disease	0.000481	0.00713	CcSEcCtD
Alvimopan—Urinary tract disorder—Valsartan—coronary artery disease	0.000479	0.00709	CcSEcCtD
Alvimopan—Urinary tract disorder—Olmesartan—coronary artery disease	0.000477	0.00706	CcSEcCtD
Alvimopan—Connective tissue disorder—Valsartan—coronary artery disease	0.000477	0.00706	CcSEcCtD
Alvimopan—Urethral disorder—Valsartan—coronary artery disease	0.000476	0.00704	CcSEcCtD
Alvimopan—Connective tissue disorder—Olmesartan—coronary artery disease	0.000474	0.00703	CcSEcCtD
Alvimopan—Flatulence—Clopidogrel—coronary artery disease	0.000474	0.00702	CcSEcCtD
Alvimopan—Back pain—Fenofibrate—coronary artery disease	0.000474	0.00701	CcSEcCtD
Alvimopan—Urethral disorder—Olmesartan—coronary artery disease	0.000473	0.00701	CcSEcCtD
Alvimopan—Flatulence—Lovastatin—coronary artery disease	0.000471	0.00698	CcSEcCtD
Alvimopan—Malnutrition—Ezetimibe—coronary artery disease	0.000469	0.00694	CcSEcCtD
Alvimopan—Back pain—Clopidogrel—coronary artery disease	0.000466	0.00689	CcSEcCtD
Alvimopan—Back pain—Lovastatin—coronary artery disease	0.000462	0.00685	CcSEcCtD
Alvimopan—Flatulence—Ezetimibe—coronary artery disease	0.000462	0.00684	CcSEcCtD
Alvimopan—Dyspepsia—Gemfibrozil—coronary artery disease	0.000461	0.00683	CcSEcCtD
Alvimopan—Malnutrition—Eplerenone—coronary artery disease	0.000459	0.0068	CcSEcCtD
Alvimopan—Back pain—Ezetimibe—coronary artery disease	0.000454	0.00672	CcSEcCtD
Alvimopan—Anaemia—Fenofibrate—coronary artery disease	0.000453	0.0067	CcSEcCtD
Alvimopan—Flatulence—Eplerenone—coronary artery disease	0.000452	0.0067	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.000452	0.00669	CcSEcCtD
Alvimopan—Dyspepsia—Ticagrelor—coronary artery disease	0.00045	0.00667	CcSEcCtD
Alvimopan—Constipation—Gemfibrozil—coronary artery disease	0.000448	0.00663	CcSEcCtD
Alvimopan—Urinary tract disorder—Trandolapril—coronary artery disease	0.000445	0.0066	CcSEcCtD
Alvimopan—Anaemia—Clopidogrel—coronary artery disease	0.000445	0.00659	CcSEcCtD
Alvimopan—Back pain—Eplerenone—coronary artery disease	0.000444	0.00657	CcSEcCtD
Alvimopan—Connective tissue disorder—Trandolapril—coronary artery disease	0.000443	0.00656	CcSEcCtD
Alvimopan—Benazepril—MTHFR—coronary artery disease	0.000442	0.223	CrCbGaD
Alvimopan—Urethral disorder—Trandolapril—coronary artery disease	0.000442	0.00655	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.000442	0.00654	CcSEcCtD
Alvimopan—Flatulence—Simvastatin—coronary artery disease	0.000441	0.00653	CcSEcCtD
Alvimopan—Urinary tract disorder—Telmisartan—coronary artery disease	0.000438	0.00648	CcSEcCtD
Alvimopan—Constipation—Ticagrelor—coronary artery disease	0.000437	0.00648	CcSEcCtD
Alvimopan—Connective tissue disorder—Telmisartan—coronary artery disease	0.000435	0.00645	CcSEcCtD
Alvimopan—Urethral disorder—Telmisartan—coronary artery disease	0.000434	0.00643	CcSEcCtD
Alvimopan—Anaemia—Ezetimibe—coronary artery disease	0.000433	0.00642	CcSEcCtD
Alvimopan—Anaemia—Eplerenone—coronary artery disease	0.000424	0.00628	CcSEcCtD
Alvimopan—Malnutrition—Valsartan—coronary artery disease	0.000422	0.00625	CcSEcCtD
Alvimopan—Malnutrition—Olmesartan—coronary artery disease	0.00042	0.00622	CcSEcCtD
Alvimopan—Flatulence—Valsartan—coronary artery disease	0.000416	0.00616	CcSEcCtD
Alvimopan—Quinapril—ACE—coronary artery disease	0.000415	0.209	CrCbGaD
Alvimopan—Anaemia—Simvastatin—coronary artery disease	0.000413	0.00612	CcSEcCtD
Alvimopan—Urinary tract disorder—Perindopril—coronary artery disease	0.000413	0.00612	CcSEcCtD
Alvimopan—Malnutrition—Niacin—coronary artery disease	0.000411	0.00608	CcSEcCtD
Alvimopan—Urethral disorder—Perindopril—coronary artery disease	0.00041	0.00607	CcSEcCtD
Alvimopan—Back pain—Valsartan—coronary artery disease	0.000409	0.00605	CcSEcCtD
Alvimopan—Back pain—Olmesartan—coronary artery disease	0.000407	0.00602	CcSEcCtD
Alvimopan—Dyspepsia—Rosuvastatin—coronary artery disease	0.000405	0.006	CcSEcCtD
Alvimopan—Flatulence—Niacin—coronary artery disease	0.000405	0.00599	CcSEcCtD
Alvimopan—Urinary tract disorder—Furosemide—coronary artery disease	0.000402	0.00595	CcSEcCtD
Alvimopan—Urethral disorder—Furosemide—coronary artery disease	0.000399	0.0059	CcSEcCtD
Alvimopan—Flatulence—Pravastatin—coronary artery disease	0.000398	0.0059	CcSEcCtD
Alvimopan—Dyspepsia—Acetylsalicylic acid—coronary artery disease	0.000394	0.00583	CcSEcCtD
Alvimopan—Constipation—Rosuvastatin—coronary artery disease	0.000394	0.00583	CcSEcCtD
Alvimopan—Malnutrition—Trandolapril—coronary artery disease	0.000393	0.00581	CcSEcCtD
Alvimopan—Anaemia—Olmesartan—coronary artery disease	0.000388	0.00575	CcSEcCtD
Alvimopan—Flatulence—Trandolapril—coronary artery disease	0.000387	0.00573	CcSEcCtD
Alvimopan—Malnutrition—Telmisartan—coronary artery disease	0.000386	0.00571	CcSEcCtD
Alvimopan—Flatulence—Enalapril—coronary artery disease	0.000385	0.00571	CcSEcCtD
Alvimopan—Flatulence—Telmisartan—coronary artery disease	0.00038	0.00563	CcSEcCtD
Alvimopan—Back pain—Trandolapril—coronary artery disease	0.00038	0.00562	CcSEcCtD
Alvimopan—Back pain—Enalapril—coronary artery disease	0.000378	0.0056	CcSEcCtD
Alvimopan—Anaemia—Pravastatin—coronary artery disease	0.000374	0.00553	CcSEcCtD
Alvimopan—Back pain—Telmisartan—coronary artery disease	0.000373	0.00552	CcSEcCtD
Alvimopan—Malnutrition—Perindopril—coronary artery disease	0.000364	0.00539	CcSEcCtD
Alvimopan—Anaemia—Trandolapril—coronary artery disease	0.000363	0.00537	CcSEcCtD
Alvimopan—Anaemia—Enalapril—coronary artery disease	0.000361	0.00535	CcSEcCtD
Alvimopan—Benazepril—ACE—coronary artery disease	0.000361	0.182	CrCbGaD
Alvimopan—Flatulence—Perindopril—coronary artery disease	0.000359	0.00531	CcSEcCtD
Alvimopan—Anaemia—Telmisartan—coronary artery disease	0.000356	0.00528	CcSEcCtD
Alvimopan—Malnutrition—Furosemide—coronary artery disease	0.000354	0.00524	CcSEcCtD
Alvimopan—Back pain—Perindopril—coronary artery disease	0.000352	0.00522	CcSEcCtD
Alvimopan—Dyspepsia—Fenofibrate—coronary artery disease	0.000352	0.00521	CcSEcCtD
Alvimopan—Flatulence—Furosemide—coronary artery disease	0.000349	0.00517	CcSEcCtD
Alvimopan—Anaemia—Captopril—coronary artery disease	0.000347	0.00513	CcSEcCtD
Alvimopan—Dyspepsia—Clopidogrel—coronary artery disease	0.000346	0.00512	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000345	0.00511	CcSEcCtD
Alvimopan—Dyspepsia—Lovastatin—coronary artery disease	0.000343	0.00509	CcSEcCtD
Alvimopan—Constipation—Fenofibrate—coronary artery disease	0.000342	0.00506	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000339	0.00502	CcSEcCtD
Alvimopan—Dyspepsia—Ezetimibe—coronary artery disease	0.000337	0.00499	CcSEcCtD
Alvimopan—Anaemia—Perindopril—coronary artery disease	0.000337	0.00498	CcSEcCtD
Alvimopan—Flatulence—Losartan—coronary artery disease	0.000337	0.00498	CcSEcCtD
Alvimopan—Constipation—Clopidogrel—coronary artery disease	0.000336	0.00497	CcSEcCtD
Alvimopan—Constipation—Lovastatin—coronary artery disease	0.000334	0.00494	CcSEcCtD
Alvimopan—Connective tissue disorder—Ramipril—coronary artery disease	0.000331	0.0049	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.00033	0.00489	CcSEcCtD
Alvimopan—Back pain—Losartan—coronary artery disease	0.00033	0.00489	CcSEcCtD
Alvimopan—Dyspepsia—Eplerenone—coronary artery disease	0.00033	0.00488	CcSEcCtD
Alvimopan—Constipation—Ezetimibe—coronary artery disease	0.000327	0.00485	CcSEcCtD
Alvimopan—Anaemia—Furosemide—coronary artery disease	0.000327	0.00485	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000323	0.00479	CcSEcCtD
Alvimopan—Connective tissue disorder—Timolol—coronary artery disease	0.000323	0.00479	CcSEcCtD
Alvimopan—Dyspepsia—Simvastatin—coronary artery disease	0.000321	0.00476	CcSEcCtD
Alvimopan—Constipation—Eplerenone—coronary artery disease	0.00032	0.00474	CcSEcCtD
Alvimopan—Anaemia—Losartan—coronary artery disease	0.000316	0.00467	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000315	0.00467	CcSEcCtD
Alvimopan—Constipation—Simvastatin—coronary artery disease	0.000312	0.00462	CcSEcCtD
Alvimopan—Ketoprofen—CXCL8—coronary artery disease	0.000304	0.153	CrCbGaD
Alvimopan—Dyspepsia—Valsartan—coronary artery disease	0.000303	0.00449	CcSEcCtD
Alvimopan—Dyspepsia—Olmesartan—coronary artery disease	0.000302	0.00447	CcSEcCtD
Alvimopan—Urinary tract disorder—Lisinopril—coronary artery disease	0.000301	0.00446	CcSEcCtD
Alvimopan—Urethral disorder—Lisinopril—coronary artery disease	0.000299	0.00443	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000298	0.00441	CcSEcCtD
Alvimopan—Indinavir—CYP2C19—coronary artery disease	0.000297	0.149	CrCbGaD
Alvimopan—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000296	0.00439	CcSEcCtD
Alvimopan—Dyspepsia—Niacin—coronary artery disease	0.000295	0.00437	CcSEcCtD
Alvimopan—Constipation—Valsartan—coronary artery disease	0.000295	0.00436	CcSEcCtD
Alvimopan—Constipation—Olmesartan—coronary artery disease	0.000293	0.00434	CcSEcCtD
Alvimopan—Malnutrition—Ramipril—coronary artery disease	0.000293	0.00434	CcSEcCtD
Alvimopan—Dyspepsia—Pravastatin—coronary artery disease	0.00029	0.0043	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Niacin—coronary artery disease	0.000289	0.00428	CcSEcCtD
Alvimopan—Malnutrition—Timolol—coronary artery disease	0.000286	0.00424	CcSEcCtD
Alvimopan—Constipation—Pravastatin—coronary artery disease	0.000282	0.00418	CcSEcCtD
Alvimopan—Dyspepsia—Trandolapril—coronary artery disease	0.000282	0.00418	CcSEcCtD
Alvimopan—Dyspepsia—Enalapril—coronary artery disease	0.000281	0.00416	CcSEcCtD
Alvimopan—Dyspepsia—Telmisartan—coronary artery disease	0.000277	0.0041	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000277	0.0041	CcSEcCtD
Alvimopan—Constipation—Trandolapril—coronary artery disease	0.000274	0.00406	CcSEcCtD
Alvimopan—Constipation—Enalapril—coronary artery disease	0.000273	0.00404	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000272	0.00402	CcSEcCtD
Alvimopan—Dyspepsia—Captopril—coronary artery disease	0.000269	0.00399	CcSEcCtD
Alvimopan—Constipation—Telmisartan—coronary artery disease	0.000269	0.00399	CcSEcCtD
Alvimopan—Malnutrition—Lisinopril—coronary artery disease	0.000266	0.00393	CcSEcCtD
Alvimopan—Constipation—Captopril—coronary artery disease	0.000262	0.00388	CcSEcCtD
Alvimopan—Flatulence—Lisinopril—coronary artery disease	0.000262	0.00388	CcSEcCtD
Alvimopan—Dyspepsia—Perindopril—coronary artery disease	0.000262	0.00387	CcSEcCtD
Alvimopan—Back pain—Lisinopril—coronary artery disease	0.000257	0.0038	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000257	0.0038	CcSEcCtD
Alvimopan—Constipation—Perindopril—coronary artery disease	0.000254	0.00376	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000249	0.00369	CcSEcCtD
Alvimopan—Constipation—Furosemide—coronary artery disease	0.000247	0.00366	CcSEcCtD
Alvimopan—Anaemia—Lisinopril—coronary artery disease	0.000245	0.00364	CcSEcCtD
Alvimopan—Dyspepsia—Losartan—coronary artery disease	0.000245	0.00363	CcSEcCtD
Alvimopan—Constipation—Losartan—coronary artery disease	0.000238	0.00353	CcSEcCtD
Alvimopan—Dyspepsia—Ramipril—coronary artery disease	0.00021	0.00312	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000206	0.00306	CcSEcCtD
Alvimopan—Dyspepsia—Timolol—coronary artery disease	0.000206	0.00305	CcSEcCtD
Alvimopan—Constipation—Ramipril—coronary artery disease	0.000204	0.00303	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Timolol—coronary artery disease	0.000202	0.00299	CcSEcCtD
Alvimopan—Dyspepsia—Lisinopril—coronary artery disease	0.000191	0.00283	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000187	0.00277	CcSEcCtD
Alvimopan—Constipation—Lisinopril—coronary artery disease	0.000185	0.00275	CcSEcCtD
Alvimopan—Ketoprofen—PTGS2—coronary artery disease	8.87e-05	0.0447	CrCbGaD
Alvimopan—Ketoprofen—ALB—coronary artery disease	7.9e-05	0.0398	CrCbGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGT—coronary artery disease	1.17e-05	0.000184	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BDKRB2—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL12—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PPP2CA—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—coronary artery disease	1.17e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—F2—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL3—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL2—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6ST—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SDC1—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—F2R—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUNB—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCD—coronary artery disease	1.15e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB2—coronary artery disease	1.14e-05	0.000179	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLCB1—coronary artery disease	1.14e-05	0.000179	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCE—coronary artery disease	1.13e-05	0.000177	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—JAK2—coronary artery disease	1.13e-05	0.000177	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SOCS1—coronary artery disease	1.13e-05	0.000177	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGB—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—S100B—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HTR2A—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—C3—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR7—coronary artery disease	1.12e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDNRB—coronary artery disease	1.11e-05	0.000175	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SOCS3—coronary artery disease	1.11e-05	0.000174	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFBR2—coronary artery disease	1.1e-05	0.000172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KITLG—coronary artery disease	1.1e-05	0.000172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—THBS1—coronary artery disease	1.1e-05	0.000172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PSMB5—coronary artery disease	1.08e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PSMA6—coronary artery disease	1.08e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—F2—coronary artery disease	1.08e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP3—coronary artery disease	1.07e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT5A—coronary artery disease	1.07e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ITGAV—coronary artery disease	1.07e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGT—coronary artery disease	1.06e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KNG1—coronary artery disease	1.06e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CREB1—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGTR1—coronary artery disease	1.06e-05	0.000166	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDNRA—coronary artery disease	1.05e-05	0.000165	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CYBA—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB1—coronary artery disease	1.05e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DUSP6—coronary artery disease	1.04e-05	0.000163	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOB—coronary artery disease	1.04e-05	0.000163	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL2—coronary artery disease	1.04e-05	0.000163	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6R—coronary artery disease	1.03e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—coronary artery disease	1.03e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLG—coronary artery disease	1.03e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—coronary artery disease	1.03e-05	0.000161	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—JAK2—coronary artery disease	1.02e-05	0.000161	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLAT—coronary artery disease	1.02e-05	0.000161	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EDN1—coronary artery disease	1.02e-05	0.00016	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—coronary artery disease	1.01e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—coronary artery disease	1e-05	0.000157	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF1—coronary artery disease	9.98e-06	0.000157	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CSF2—coronary artery disease	9.98e-06	0.000157	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LPL—coronary artery disease	9.91e-06	0.000156	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCE—coronary artery disease	9.89e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—JAK2—coronary artery disease	9.89e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL12—coronary artery disease	9.87e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BDKRB2—coronary artery disease	9.87e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SOCS1—coronary artery disease	9.87e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—coronary artery disease	9.86e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—S100B—coronary artery disease	9.84e-06	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—F2—coronary artery disease	9.83e-06	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RPS6KB1—coronary artery disease	9.82e-06	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MEF2C—coronary artery disease	9.82e-06	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6ST—coronary artery disease	9.79e-06	0.000154	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SOCS3—coronary artery disease	9.75e-06	0.000153	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUNB—coronary artery disease	9.69e-06	0.000152	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLCB1—coronary artery disease	9.65e-06	0.000152	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KITLG—coronary artery disease	9.63e-06	0.000151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFBR2—coronary artery disease	9.63e-06	0.000151	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ITGB3—coronary artery disease	9.57e-06	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR7—coronary artery disease	9.45e-06	0.000148	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP3—coronary artery disease	9.41e-06	0.000148	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT5A—coronary artery disease	9.41e-06	0.000148	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—coronary artery disease	9.34e-06	0.000147	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PPP2CA—coronary artery disease	9.3e-06	0.000146	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCD—coronary artery disease	9.13e-06	0.000143	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOB—coronary artery disease	9.1e-06	0.000143	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—coronary artery disease	9.02e-06	0.000142	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITGAV—coronary artery disease	9.01e-06	0.000141	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KNG1—coronary artery disease	8.98e-06	0.000141	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—JAK2—coronary artery disease	8.98e-06	0.000141	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EDN1—coronary artery disease	8.96e-06	0.000141	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—coronary artery disease	8.95e-06	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CREB1—coronary artery disease	8.95e-06	0.00014	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HTR2A—coronary artery disease	8.93e-06	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR1—coronary artery disease	8.93e-06	0.00014	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—C3—coronary artery disease	8.92e-06	0.00014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—coronary artery disease	8.89e-06	0.000139	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—coronary artery disease	8.76e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CSF2—coronary artery disease	8.75e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF1—coronary artery disease	8.75e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6R—coronary artery disease	8.73e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—coronary artery disease	8.72e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLG—coronary artery disease	8.7e-06	0.000137	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LPL—coronary artery disease	8.69e-06	0.000136	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MEF2C—coronary artery disease	8.61e-06	0.000135	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RPS6KB1—coronary artery disease	8.61e-06	0.000135	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HIF1A—coronary artery disease	8.51e-06	0.000134	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGT—coronary artery disease	8.48e-06	0.000133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—coronary artery disease	8.47e-06	0.000133	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ITGB3—coronary artery disease	8.39e-06	0.000132	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCE—coronary artery disease	8.36e-06	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—JAK2—coronary artery disease	8.35e-06	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SOCS1—coronary artery disease	8.34e-06	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—S100B—coronary artery disease	8.32e-06	0.000131	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LEP—coronary artery disease	8.31e-06	0.00013	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOE—coronary artery disease	8.31e-06	0.00013	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SOCS3—coronary artery disease	8.24e-06	0.000129	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOA1—coronary artery disease	8.21e-06	0.000129	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—coronary artery disease	8.19e-06	0.000129	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PPP2CA—coronary artery disease	8.15e-06	0.000128	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KITLG—coronary artery disease	8.14e-06	0.000128	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFBR2—coronary artery disease	8.14e-06	0.000128	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KDR—coronary artery disease	8.14e-06	0.000128	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK14—coronary artery disease	8.08e-06	0.000127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCD—coronary artery disease	8.01e-06	0.000126	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT5A—coronary artery disease	7.96e-06	0.000125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP3—coronary artery disease	7.96e-06	0.000125	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ESR1—coronary artery disease	7.93e-06	0.000124	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR2A—coronary artery disease	7.83e-06	0.000123	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—F2—coronary artery disease	7.83e-06	0.000123	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FN1—coronary artery disease	7.83e-06	0.000123	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—C3—coronary artery disease	7.82e-06	0.000123	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6ST—coronary artery disease	7.8e-06	0.000122	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NFKBIA—coronary artery disease	7.74e-06	0.000121	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOB—coronary artery disease	7.69e-06	0.000121	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—coronary artery disease	7.63e-06	0.00012	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—JAK2—coronary artery disease	7.59e-06	0.000119	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDN1—coronary artery disease	7.57e-06	0.000119	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—coronary artery disease	7.51e-06	0.000118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KIT—coronary artery disease	7.5e-06	0.000118	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HIF1A—coronary artery disease	7.46e-06	0.000117	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGT—coronary artery disease	7.43e-06	0.000117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CSF2—coronary artery disease	7.4e-06	0.000116	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF1—coronary artery disease	7.4e-06	0.000116	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LPL—coronary artery disease	7.34e-06	0.000115	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LEP—coronary artery disease	7.28e-06	0.000114	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOE—coronary artery disease	7.28e-06	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MEF2C—coronary artery disease	7.28e-06	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RPS6KB1—coronary artery disease	7.28e-06	0.000114	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOA1—coronary artery disease	7.2e-06	0.000113	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GSK3B—coronary artery disease	7.19e-06	0.000113	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—coronary artery disease	7.14e-06	0.000112	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CREB1—coronary artery disease	7.14e-06	0.000112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KDR—coronary artery disease	7.14e-06	0.000112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITGB3—coronary artery disease	7.09e-06	0.000111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK14—coronary artery disease	7.09e-06	0.000111	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—coronary artery disease	6.98e-06	0.00011	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6R—coronary artery disease	6.96e-06	0.000109	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ESR1—coronary artery disease	6.95e-06	0.000109	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	6.92e-06	0.000109	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	6.89e-06	0.000108	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FN1—coronary artery disease	6.87e-06	0.000108	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—F2—coronary artery disease	6.87e-06	0.000108	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF1—coronary artery disease	6.86e-06	0.000108	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	6.84e-06	0.000107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	6.83e-06	0.000107	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	6.79e-06	0.000107	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	6.77e-06	0.000106	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	6.62e-06	0.000104	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C3—coronary artery disease	6.61e-06	0.000104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KIT—coronary artery disease	6.57e-06	0.000103	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.53e-06	0.000102	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	6.52e-06	0.000102	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF2—coronary artery disease	6.31e-06	9.9e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	6.31e-06	9.9e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	6.31e-06	9.9e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGT—coronary artery disease	6.28e-06	9.86e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—coronary artery disease	6.26e-06	9.82e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CREB1—coronary artery disease	6.26e-06	9.82e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOS3—coronary artery disease	6.22e-06	9.77e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LEP—coronary artery disease	6.16e-06	9.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOE—coronary artery disease	6.16e-06	9.66e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—coronary artery disease	6.12e-06	9.61e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6R—coronary artery disease	6.1e-06	9.58e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOA1—coronary artery disease	6.08e-06	9.55e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JAK2—coronary artery disease	6.05e-06	9.49e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KDR—coronary artery disease	6.03e-06	9.47e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF1—coronary artery disease	6.02e-06	9.45e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	5.99e-06	9.4e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	5.99e-06	9.4e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	5.93e-06	9.3e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ESR1—coronary artery disease	5.88e-06	9.22e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—F2—coronary artery disease	5.8e-06	9.11e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FN1—coronary artery disease	5.8e-06	9.11e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	5.78e-06	9.07e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	5.74e-06	9e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.72e-06	8.98e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	5.72e-06	8.97e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KIT—coronary artery disease	5.56e-06	8.72e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF2—coronary artery disease	5.53e-06	8.68e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	5.52e-06	8.66e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOS3—coronary artery disease	5.46e-06	8.56e-05	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	5.33e-06	8.37e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	5.33e-06	8.37e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JAK2—coronary artery disease	5.3e-06	8.32e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—coronary artery disease	5.29e-06	8.3e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CREB1—coronary artery disease	5.29e-06	8.3e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CASP3—coronary artery disease	5.28e-06	8.29e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—coronary artery disease	5.25e-06	8.24e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	5.2e-06	8.16e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—coronary artery disease	5.17e-06	8.12e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6R—coronary artery disease	5.16e-06	8.1e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCND1—coronary artery disease	5.14e-06	8.07e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF1—coronary artery disease	5.09e-06	7.98e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.06e-06	7.95e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—coronary artery disease	4.99e-06	7.84e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	4.84e-06	7.6e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	4.84e-06	7.6e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.84e-06	7.59e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.83e-06	7.58e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF2—coronary artery disease	4.68e-06	7.34e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	4.68e-06	7.34e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CASP3—coronary artery disease	4.63e-06	7.27e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOS3—coronary artery disease	4.61e-06	7.24e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—coronary artery disease	4.6e-06	7.22e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCND1—coronary artery disease	4.51e-06	7.08e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	4.48e-06	7.04e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JAK2—coronary artery disease	4.48e-06	7.03e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.39e-06	6.89e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—coronary artery disease	4.38e-06	6.87e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	4.25e-06	6.66e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	4.11e-06	6.46e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	4.09e-06	6.42e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	4.04e-06	6.33e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	3.95e-06	6.2e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	3.93e-06	6.17e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP3—coronary artery disease	3.92e-06	6.15e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—coronary artery disease	3.89e-06	6.11e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCND1—coronary artery disease	3.81e-06	5.98e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—coronary artery disease	3.7e-06	5.81e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	3.61e-06	5.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	3.59e-06	5.63e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	3.54e-06	5.55e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	3.5e-06	5.5e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	3.32e-06	5.21e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—coronary artery disease	3.1e-06	4.87e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	3.07e-06	4.82e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	3.05e-06	4.79e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	2.99e-06	4.69e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—coronary artery disease	2.86e-06	4.49e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—coronary artery disease	2.72e-06	4.27e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.59e-06	4.07e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—coronary artery disease	2.51e-06	3.94e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—coronary artery disease	2.3e-06	3.61e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—coronary artery disease	2.12e-06	3.33e-05	CbGpPWpGaD
